Skip to main content

Cell Wall Constituents of Candida Albicans as Biological Response Modifiers

  • Chapter
Combination Therapies

Abstract

Candida albicans is an opportunistic fungal agent which has become a highly prevalent and incident cause of disease, especially life-threatening in neutropenic, bone-marrow transplanted subjects with underlying malignant hemopathy1,2. An extensive experimental evidence demonstrates that this fungus, and materials extracted from it, can also be used to influence or modify multiple biologic functions3,4. A particular point of interest in the “Biological Response Modifier” (BRM)-activities of Candida, that make this microorganism quite particular in comparison to other more popular microbial immunomodulators (for instance, BCG), is that Candida is a human commensal. Thus, almost every normal subject is primed for immune response to candidal antigens, as shown by the presence in its serum of measurable, sometimes elevated, levels of specific antibodies, and positive cell-mediated response to Candida antigens 5,6. While generating restrictions to the use of certain fungal materials as immunomodulators (mostly concerning undesired hypersensitivity reactions) the human commensalism also tells us that Candida-induced immunomodulation may take place under natural conditions and can be easily amplified. A rather dramatic example of this amplification is the generation of LAK- like effectors following Candida vaccination of normal mice7 or exposure of peripheral blood mononuclear cells (PBMC) from normal human donors to a mannoprotein extract of C. albicans 8. Moreover, certain fungal products are potent recall antigens to probe the efficiency of the immune system, both in normal and pathological conditions9,10 Most of the BRM-effects of C. albicans are mediated by the glucan and the mannoprotein constituents of the fungal cell wall4. In this note, we will mostly address the latter components (hereafter referred to as MP), and will attempt to summarize some of our recent results on the immunogenic and immunomodulatory effects of a purified and chemically-characterized mannoprotein fraction (F2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. F. C. Odds, Candida infections: an overview, CRC Crit. Rev. Microbiol. 15:1 (1987).

    Article  CAS  Google Scholar 

  2. R. Horn, B. Wong, T. E. Kiehn, and D. Armstrong, Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy, Rev. Infect. Dis. 7:646 (1985).

    Article  PubMed  CAS  Google Scholar 

  3. A. Cassone, P. Marconi, F. Bistoni, E. Mattia, G. Sbaraglia, E. Garaci, and E. Bonmassar, Immunoadjuvant effects of Candida albicans andits cell wall fractions in a mouse lymphoma model, Cancer Immunol. Immunother. 10:181 (1981).

    Article  Google Scholar 

  4. A. Cassone, Cell wall of Candida albicans, its functions and impact on the host, Current Topics Med. Mycol., 3:249 (1989).

    Google Scholar 

  5. F. C. Odds, “Candida and candidosis”, Baillière Tindall, London (1988).

    Google Scholar 

  6. C. M. Ausiello, G. C. Spagnoli, M. Boccanera, I. Casalinuovo, E Malavasi, C. U. Casciani, and A. Cassone, Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions, J. Med. Microbiol. 22:195 (1986).

    Article  PubMed  CAS  Google Scholar 

  7. L. Scaringi, P. Cornacchione, E. Rosati, M. Boccanera, A. Cassone, E Bistoni, and P. Marconi, Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans, Cell. Immunol. 129:271 (1990).

    Article  PubMed  CAS  Google Scholar 

  8. C. M. Ausiello, C. Palma, G. C. Spagnoli, A. Piazza, C. U. Casciani, and A. Cassone, Cytotoxic effectors in human peripheral blood mononuclear cells induced by a mannoprotein complex of Candida albicans: a comparison with interleukin- 2 activate killer cells, Cell. Immunol. 121:349 (1989).

    Article  PubMed  CAS  Google Scholar 

  9. C. M. Ausiello, C. Palma, A. Maleci, G. C. Spagnoli, C. Amici, G. Antonelli, C. U. Casciani, and A. Cassone. Cell-mediated cytotoxicity and cytokine production in peripheral blood mononuclear cells of glioma patients. Eur. J. Cancer, in press (1991).

    Google Scholar 

  10. I. Quinti, C. Palma, E. C. Guerra, M. J. Gomez, I. Mezzaroma, F. Aiuti and A. Cassone. Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects. Exptl. Clin. Immunol., in press (1991).

    Google Scholar 

  11. A. Torosantucci, M. Boccanera, I. Casalinuovo, G. Pellegrini and A. Cassone. Differences in the antigenic expression of immunomodulatory mannoprotein constituents on yeast and mycelial forms of Candida albicans. J. Gen. Microbiol. 136:1421 (1990).

    PubMed  CAS  Google Scholar 

  12. A. Torosantucci, C. Palma, M. Boccanera, C. M. Ausiello, G. C. Spagnoli and A. Cassone. Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans. J. Gen. Microbiol. 136:2155 (1990).

    PubMed  CAS  Google Scholar 

  13. E. W. Carrow, and J. Domer. Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein. Infect. Immun. 49:172 (1985).

    PubMed  CAS  Google Scholar 

  14. J. Domer, K. Elkins, D. Ennist and P. Baker. Modulation of immune responses by surface polysaccarides of Candida albicans. Rev. Infect. Dis. 10:419 (1988).

    Google Scholar 

  15. C. F. Cuff, C. M. Rogers, B. J. Lamb, and T. J. Rogers. Induction of suppressor cells in vitro by Candida albicans. Cell. Immunol. 100:47 (1986).

    Article  PubMed  CAS  Google Scholar 

  16. C. D. Wright, M. J. Herron, G. R. Gray, B. Holmes, and R. D. Nelson. Influence of yeast mannan on human neutrophil functions: inhibition of release of mieloperoxidase related to carbohydrate-binding properties of the enzyme. Infect. Immun. 32:731 (1981).

    PubMed  CAS  Google Scholar 

  17. R. Podzorski, G. R. Gray and R. D. Nelson. Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in in vitro. J. Immunol. 144:707 (1990).

    PubMed  CAS  Google Scholar 

  18. J. Tollemar, O. Ringdèn, and K. Holmberg Candida albicans: mannan and protein activation of cells from various human lymphoid organs. Scand. J. Immunol. 30:473 (1989).

    CAS  Google Scholar 

  19. A. L. Luzzati, E. Giacomini, A. Torosantucci, L. Giordani and A. Cassone. A mannoprotein constituent of Candida albicans cooperates with antigenic in the induction of a specific primary antibody response in cultures of human lymphocytes. J. Biol. Regul. Horn. Agents. 4:142 (1990).

    CAS  Google Scholar 

  20. A. Vecchiarelli, M. Puliti, A. Torosantucci, A. Cassone and F. Bistoni. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall. Cell. Immunol. 134:65 (1991).

    Article  PubMed  CAS  Google Scholar 

  21. J. Y. Djeu and D. Kay-Blanchard. Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor. J. Immunol. 139:2761 (1987).

    PubMed  CAS  Google Scholar 

  22. A. Saxena and R. Calderone. Purification and characterization of the extracellular C3d-binding protein of Candida albicans. Infect. Immun. 58:309 (1990).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Cassone, A., Torosantucci, A., Palma, C., Gomez, M.J., Ausiello, C.M., Djeu, J.Y. (1992). Cell Wall Constituents of Candida Albicans as Biological Response Modifiers. In: Goldstein, A.L., Garaci, E. (eds) Combination Therapies. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3340-5_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3340-5_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6472-6

  • Online ISBN: 978-1-4615-3340-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics